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Abstract 
Cardiac muscle creation during embryogenesis requires extracellular instructive signals 
that are regulated precisely in time and space, intersecting with intracellular genetic programs 
that confer or fashion cells’ ability to respond. Unmasking the essential signals for cardiac 
lineage decisions has paramount importance for cardiac development and regenerative 
medicine, including the directed differentiation of progenitor and stem cells to a cardiac muscle 
fate.  
 Circulation Research Manuscript #CIRCRESAHA/2010/223792 - R1 Review
Noseda, CIRCRESAHA/2010/223792 (revised) 
 3 
Abbreviations 
  
ActR Activin receptor 
AHF Anterior heart field 
Alk Activin receptor-like kinase 
BMP Bone morphogenetic protein 
BMPR Bone morphogenetic protein receptor 
CaMK Calmodulin-dependent protein kinase 
Dkk Dickkopf 
dpc Days post-coitum 
Dpp decapentaplegic 
Dvl, dsh Disheveled 
EB Embryoid body 
EPC Endothelial progenitor cell 
ESC Embryonic stem cell 
FGF Fibroblast growth factor 
FGFR FGF receptor 
Frz, Fz Frizzled 
GSK-3β Glycogen synthase kinase-3β 
hESC Human embryonic stem cell 
Hh Hedgehog 
HSC Hematopoietic stem cell 
Htl Heartless 
iPSC Induced pluripotent stem cell 
JNK Jun N-terminal kinase 
Lrp Low-density lipoprotein receptor-related protein 
MAML Mastermind-like 
MAPK Mitogen-activated protein kinase 
mESC Mouse embryonic stem cell 
MSC Mesenchymal stem cell 
MyHC Myosin heavy chain 
NICD Notch intracellular domain 
PDGF Platelet-derived growth factor 
PI3K Phosphatidylinositol-3-kinase 
PKC Protein kinase C 
PLC Phospholipase C 
Ptc Patched 
RA Retinoic acid 
Raldh2 Retinaldehyde dehydrogenase 2 
Rbpj Recombination signal binding protein for immunoglobulin kappa J region 
RNAi RNA interference 
ROCK Rho-associated protein kinase 
Sfrp Secreted Frizzled-related protein 
SHF Second heart field 
Shh Sonic hedgehog 
shRNA Short hairpin RNA 
Smo Smoothened 
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Tcf T cell-specific transcription factor 
TGFβ Transforming growth factor-β 
Wg Wingless 
Wnt Wg (wingless)/Int 
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The origin of cardiac muscle cells, like developmental origins more generally, entails cell 
specification or commitment, namely, the progressive restriction of cell fate. The totipotent 
fertilized egg gives rise to all cells of the embryo without exception, plus extra-embryonic tissues 
like the placenta and trophoblast. At the time of gastrulation—the migration and invagination of 
cells that formerly comprised a simple hollow ball called the blastula—unspecialized cells 
become committed to create three germ layers: the endoderm (future gut, liver, pancreas and 
lung), ectoderm (future nervous system and skin), and mesoderm (future skeletal muscle, bone, 
tendon, hematopoietic cells, and cardiovascular system). This process is directed by antecedent 
spatial asymmetries laid down in the blastula, often involving the same signaling pathways that 
are redeployed later in development to drive cell fate decisions for lineage and tissue-specificity. 
In both settings, superimposed on “cell-autonomous” events (those intrinsic to a cell), are “cell 
non-autonomous” events, which entail neighboring or long-range signals including concentration 
gradients of instructive molecules known as morphogens. Among the recurring players are Wnt 
proteins, fibroblast growth factors (FGF), and many members of the transforming growth factor-
β (TGFβ) superfamily, including bone morphogenetic proteins (BMPs), Nodal, and Activin.  
These extracellular signals for cardiac muscle creation comprise the focus of the present 
review, all widely implicated throughout the ontogenetic zoo. Whereas the heart’s geometry 
differs, the inductive circuits are ancestral and conserved, as is the transcription machinery that 
ultimately imparts the cardiac muscle fate. Such information is crucial not merely to comprehend 
the heart’s formation in reductive terms, or even to distill the knowledge into quantitative 
network models, but also for a myriad of bench-to-bedside translational applications. Cues that 
drive heart formation in the embryo have already proven themselves effective means to 
augment cardiac muscle creation by both embryonic and adult stem cells. A further illustration is 
provided by the successful reprogramming of adult fibroblasts into cardiac muscle using three 
defined cardiogenic transcription factors 1. 
In this review, findings are presented for each major cardiogenic pathway in turn, and for 
clarity within each pathway the evidence is organized by model system. Each section begins 
with the avian and amphibian models in which a dissection of cardiogenesis first was 
undertaken, then progresses through whole-animal studies in genetically tractable species (flies, 
fish, and mice) and ends with discussions of mammalian progenitor and stem cells themselves. 
Brief summaries introduce the key features of each major signaling cascade, shown 
schematically in Figure 1, and encapsulate the key cross-species comparisons. The pathways’ 
positive and negative effects on relevant lineage decisions that culminate in cardiac muscle 
creation are depicted in Figure 2 and in higher detail for zebrafish in Figure 3. Both latter figures 
emphasize the timing- and stage-specific consequences, which are intricate and multifarious.  
For background details of heart formation in the model organisms, comparative anatomy, 
and the transcriptional apparatus for cardiac myogenesis, see references 2-4. 
Tissue-to-tissue 
To expose the extracellular signals that drive cardiac lineage decisions, various species 
offer contrasting technical advantages 2, 3. Genetic benefits range from sheer tractability (e.g., 
the panoply of germline, tissue-restricted, and drug-inducible mutations that can be engineered 
in mice, or the ease of gene suppression by morpholino oligonucleotides in frogs and fish), to 
simplicity (the relative lack of redundant paralogous genes in the sea squirt, Ciona intestinalis), 
to the power of “genetically unbiased” saturation mutagenesis of the whole genome in flies, fish, 
Ciona and mice. Another point of attack, though, involves species whose embryos develop 
outside the mother, offering unsurpassed access to microdissection and transplantation, 
beginning with amphibians and avians. As a century-long exemplar for developmental biology, 
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the patterning of amphibian embryos was known to require a region known as the Spemann-
Mangold organizer, located within the equatorial zone of blastula stage embryos at the 
involuting blastopore lip 5. The organizer results from the intersection of three maternal signals, 
two meso-endoderm inducers from the vegetal pole plus a dorsal modifying signal, conferred by 
the TGFβ and Wnt families respectively 6, 7. The dorsal half of Xenopus embryos bisected at this 
stage is able to generate complete embryos, whereas the ventral half cannot develop axial 
structures. To orchestrate the body plan in other species, the functional equivalents include 
Hensen’s node in avians, the shield in zebrafish, and the node in mice, in each case one tissue 
generating instructive cues that pattern another 8. 
Like understanding of the organizer itself, the earliest clues to signals for cardiac 
myogenesis (reviewed in 9, 10) pre-date by fifty years or more the biochemical identification of 
any exact molecule. These pioneering studies of heart induction in newts and salamanders 
demonstrated that (i) extirpating endoderm at the time of neural tube development, the neurula 
stage, prevents heart formation 11; (ii) the instructive activity is confined to anterior (pharyngeal) 
endoderm, which suffices to drive heart formation in explant cultures 12; (iii) the axolotl mutation 
cardiac lethal involves a defect in this signal and is rescued by grafting mutant hearts into wild-
type hosts 13 or co-culturing mutant heart explants with wild-type endoderm 14. More recent 
studies of cardiac development in amphibians center on the African clawed frog Xenopus laevis. 
Specification of the heart-forming region in Xenopus occurs earlier than in the urodeles above, 
before the germ layers are readily separable by dissection, and the impact of removing 
pharyngeal endoderm is partial at most 9. More extensive removal of Xenopus endoderm 
revealed the essential role for this layer and, together with the organizer, could even induce a 
second heart in isolated ventral tissue 10. Cardiac myogenesis was inhibited or blocked by 
ultraviolet light and other treatments that promote ventral cell fates 15; conversely, the heart was 
enlarged by lithium, which enhances dorsoanterior determination 16.  
Similarly, in avians, a role for endoderm was implicated by removing the endoderm 17 or 
by culturing endoderm with the presumptive heart-forming region 18. In efforts to extrapolate 
such findings to mammals, the precardiac region of mouse embryos was specified—
programmed to differentiate autonomously into beating cardiac muscle— by 7.5 days post-
coitum (dpc), but required visceral endoderm to do so if put in culture even a quarter-day earlier 
19. Such experiments, like much early work in Xenopus, typically did not discriminate between 
two possibilities: can signals from endoderm promote cardiac differentiation only in cells 
committed to a cardiac muscle fate or, rather, induce an ectopic cardiac fate in cells committed 
to some other lineage?  Studies using chick-qualil co-cultures established that the cardiac-
inducing activity in anterior endoderm could even instigate cardiac specification in cells from the 
posterior primitive streak, ordinarily fated to become blood-forming 20. These experiments 
quickly led to the discovery in chick embryos of specific essential signals from anterior 
endoderm for cardiac myogenesis, detailed immediately below 21. Even in the present era of 
molecularly defined cardiogenic signals, the use of endodermal cell lines continues as a 
biologically rational trigger for cardiac muscle creation by human embryonic stem cells (ESCs) 
and induced pluripotent cells (iPSCs) 22, 23.  
Bone morphogenetic proteins 
Pathway synopsis 
The signaling machinery for BMPs largely resembles that for the TGFβ superfamily as a 
whole 24 (Figure 1). The heterotetrameric signaling receptor complex comprises two pairs of 
membrane-spanning proteins with intracellular serine-threonine kinase domains. Ligand binding 
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promotes oligomerization, whereupon the “type II” receptors phosphorylate the “type I” receptors 
in trans, within a Gly/Ser-rich motif N-terminal to the catalytic domain, activating the type I 
receptor kinase. Three type II receptors (BMPR-II, ActR-II, ActR-IIB) and an even larger number 
of type I receptors (Activin receptor-like kinases; ALKs) mediate BMP binding, e.g., BMP2 and -
4 to ALK3 and -6, but BMP9 and -10 to ALK1 and -2. The activated type I receptors, in turn, 
directly phosphorylate Smad transcription factors (Smad1/5/8 for BMPs; Smad2/3 for TGFβ and 
Activin), which then complex with a common partner or co-Smad (Smad4) and translocate to the 
nucleus. Inhibitory Smads (Smad6/7) interfere with one or both classes above. In addition, 
BMPs can activate certain signals independently of Smads, e.g., via TGFβ-activated kinase-1. 
Preceding the availability of knockdowns, knockouts, and dominant-interfering mutations for 
inhibition of this apparatus, extracellular BMP antagonists (noggin, chordin, gremlin, cerberus), 
along with ectopic expression studies, provided the initial insights into BMP function in creation 
of the heart. 
Avians 
In the chick embryo, BMPs are necessary for cardiogenic activity of anterior endoderm, 
shown by the ability of inhibitors like noggin to suppress cardiac differentiation 21, 25, 26. The 
ligands expressed in the right place and at the right time for relevance to cardiac specification 
include BMP2, -4, and -7. BMP-2-impregnated beads evoke ectopic expression of the 
cardiogenic transcription factors NKX2-5 and GATA4 in chick embryos, and soluble BMP2 or -4 
evokes cardiac differentiation in explant cultures of anterior medial mesoderm, a region that 
ordinarily does not produce heart muscle. Susceptibility to cardiac myogenesis induced by 
BMPs is not a universal response but rather a property restricted to anterior mesoderm 21. 
Asserting a direct connection between BMP signals and cardiac differentiation, functional SMAD 
binding sites exist in the 3’ enhancer of chick NKX2-5 27. BMPs also direct cells from the cranial 
paraxial mesoderm that populate the ventricular outflow tract to a cardiac rather than skeletal 
muscle fate 28, inducing at least 20 sarcomeric genes 29.  
Amphibians 
Analogous evidence exists in Xenopus 30, 31. Dominant-negative mutations of 
bmpr1a/alk3 or bmpr2 reduce or prevent heart formation, downregulating nkx2-5, though the 
initial expression of nkx2-5 is unaffected and the phenotypes can be rescued by co-injecting 
smad1 32. In other studies, suppressing the BMP pathway with smad6 or a dominant-negative 
BMP receptor reduced the number of cardiomycytes and fusion of the cardiac primordia, without 
impairing expression of nkx2-5 or gata4/5/6. Thus, in contrast to their role in other species, 
BMPs in Xenopus may be required for cardiomyocytes’ differentiation not specification, although 
a conserved 334 bp element in the tbx20 locus is directly activated by Smad1 and is necessary 
and sufficient for cardiac-specific expression of that gene 33. Differences are also seen in the 
hierarchical relationship with cardiogenic GATA factors, gata6 lying upstream of BMPs in 
Xenopus, whereas in zebrafish gata5 rescues the cardiac phenotype of swirl (Bmp2b) mutants 
34, 35. These epistatic differences between species could reflect differences in the order in which 
the core transcriptional circuitry for cardiac differentiation is established 36.  
Flies 
Though lacking a four-, three- or even two-chambered heart, Drosophila possess a 
linear heart-like tube, the dorsal vessel, which pumps hemolymph through the organism, is 
remarkably predictive of vertebrate heart specification and development up to the linear heart 
tube stage, and employs a phylogenetically conserved ensemble of cardiogenic transcription 
factors, e.g., encoded by tinman (Nkx2-5), pannier (GATA), Dmef2, dorsocross 1-3 (Tbx5), 
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neuromancer 1-2 (Tbx20), and tailup (Isl1) 37, 38. Expressed in dorsal ectoderm adjacent to the 
tinman-expressing cells, the BMP ortholog decapentaplegic (dpp) is required for tinman 
expression and dorsal vessel formation 39. This differs conspicuously from the ventral 
expression of BMPs in vertebrates, with a role in ventral structures, but conforms to the 
postulated inversion of the dorsoventral axis during evolution 40. Pannier and dorsocross are 
likewise induced by dpp 41, 42, but additional instructive signals are required for heart 
differentiation to take place, including wingless (wg), discussed below. Dorsal vessel formation 
and full levels of tinman expression also require screw (a second BMP ortholog) and tolloid (a 
protease that cleaves chordin). Possibly screw and tolloid regulate the additional signals that 
are required in concert with dpp 43. Conversely, expanding the region expressing dpp, with extra 
copies of the gene or expression driven by the yeast transcription factor GAL4, causes a 
corresponding expansion of tinman expression, though not expansion of heart tissue. Induction 
of tinman by dpp—the sine qua non of cardiac specification—is mimicked by the constitutively 
active type I dpp receptor, thickveins 44 and mediated by the Smad orthologs, medea and mad, 
which bind the tinman 3’ enhancer and are essential for tinman expression 43, 45.  
Fish 
Early work in the zebrafish mutant, swirl, deficient in bmp2b, demonstrated that a BMP 
pathway is required for both specification of the cardiac precursors and their differentiation 35 
(Figure 3). Using a milder reduction of BMP signaling, later work revealed a further role in atrial 
identity 46. Zebrafish lost-a-fin mutants have defects in the type I BMP receptor gene, alk8, and 
display a weak dorsalisation phenotype 47, 48. Lost-a-fin mutants show a strong reduction in the 
number of atrial cardiomyoctyes whereas the ventricular number is unchanged 46. Furthermore, 
although cardiac specification was affected—shown by down-regulation of gata5 and hand2 46—
nkx2.5 was unaltered 46, 49, 50. Nkx2.5-positive cardiac progenitors lie more medially within the 
heart field and fate map studies have shown this territory contributes mainly to the ventricle 51. 
Hence, the zebrafish cells destined to form the ventricle were not affected by loss of alk8, and 
presumably a redundant receptor explains the more widespread cardiac phenotype resulting 
from mutation of bmp2b. Utilising a pharmacological inhibitor of type I BMP receptors, 
dorsomorphin 52, the requirement for BMP during cardiomyocyte generation was identified as 
occurring during gastrulation, inhibition after gastrulation having no effect on cardiomyocyte 
numbers 46. Conversely, a constitutively active form of alk8 increased cardiomyocyte numbers in 
both chambers, although the ventricle was only modestly enhanced. Bmp4 and its receptor 
Acvr1l are essential to forming the proepicardial organ in zebrafish, which gives rise to the 
epicardium, cardiac fibroblasts and coronary vessels 53, and might be relevant to the activation 
of adult epicardium underlying cardiac regeneration in this species 54. 
Ciona  
The critical role of BMP signaling in cardiac myogenesis is conserved in the rudimentary 
heart of the chordate Ciona Intestinalis, a single layered U-shaped myoepithelial tube 55, 56. The 
cellular and genetic simplicity of Ciona has facilitated high-throughput in situ hybridization and 
gene disruption efforts to map genetic networks for embryogenesis in this organism 57, 58. The 
specification of primitive mesoderm to become cardiac mesoderm depends on a helix-loop-helix 
transcription factor, Mesp 59, whose two orthologs in mice play a similarly pivotal but redundant 
role 60-62. In Ciona the precardiac mesoderm (trunk ventral cells) migrate towards a source of 
BMP2/4 (ventral trunk epidermis), which is required for the precardiac gene regulatory network 
kernel via sequential activation of the GATA ortholog GATAa and Nkx2-5 ortholog NK4 at 
progressively higher levels of BMP signaling 56. 
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Mice 
Inherently, deletion of genes in the germline may reveal only genes’ earliest essential 
function, obscuring roles at later stages of development, in adults, or in a particular lineage like 
cardiac muscle. This limitation to knockouts as the erstwhile gold standard is conspicuously true 
for BMP-dependent phenotypes in mice. The essential role for BMP signaling during 
gastrulation and in forming the primitive mesoderm leads to death before 9.5 dpc upon germline 
deletion of Bmp4, Bmpr2, Alk3/Bmpr1a, Alk2/ActRIA, or the universal Smad partner, Smad4 63-
68. Placental defects confound interpreting Smad1-deficient mice 69. Cardiac morphogenesis—
not myogenesis—is abnormal in mice lacking Bmp2 or Bmp10 70, 71, conditional deletions of 
Bmp4 using Tnnt2- or Nkx2-5-Cre 72, 73, deletion of Bmp5 plus Bmp7 74, the compound 
heterozygote of Bmp2 plus Bmp4 75, null or non-functional alleles of Smad5, Smad6, or Smad7 
76-78 and compound heterozygotes lacking Smad1 plus Smad5 79. 
Through expressing Cre recombinase just in cardiac myocytes or subpopulations of 
myocytes, the Cre/lox system for conditional gene deletion has clarified many roles for Alk3 in 
cardiac morphogenesis 80-82. In contrast, ablating Alk3 closer to gastrulation provides evidence 
asserting an irreplaceable role of BMP signals for cardiac specification in the mammalian heart 
83. The primary heart field, giving rise to the future left ventricle, was virtually abolished by 
deleting Alk3 with Mesp1-Cre 83, using homologous recombination to insert Cre into the Mesp1 
locus 61, 62. In this configuration, Cre was expressed after gastrulation, shortly after mesoderm 
formation, but prior to induction of any cardiac-specific transcription factor. As the result, the first 
heart field markers Hand1 and Tbx5 were absent and the cardiac crescent not formed, whereas 
Isl1 and Fgf8, markers of the second or anterior heart field (SHF, AHF; the source of the future 
atria, right ventricle, and outflow tract) persisted in the small residuum of cardiac tissue. 
Analogously, using Mox2-Cre to delete Alk3 in the epiblast, gastrulation proceeded normally, but 
with no obvious cardiac crescent or later heart tissue 84. Using Mesp1-Cre to ablate Smad1, the 
heart tube was composed almost entirely of SHF cells 85, consistent with the results for Alk3. In 
addition, conditional deletion of Smad1 was used to implicate an overactive Bmp2/Smad1 
pathway in the ectopic specification and growth arrest of cardiac progenitor cells in mice lacking 
Nkx2-5 85. Functional evidence of a different kind, linking the BMP/Smad pathway directly to 
cardiac specification in mice, comes from in vivo promoter mapping, pinpointing a requirement 
for noggin-responsive Smad sites in the enhancers for Nkx2-5 86-88.  
Progenitor and stem cells 
Applying developmental insights from the model organisms above, exogenous growth 
factors have been utilized in efforts to direct ESC differentiation towards the cardiac muscle 
lineage. In pioneering studies, low concentrations of BMP4 and high ones of Activin A were 
found to induce alpha-myosin heavy chain (Myh6) in mouse ESCs (mESCs) 89. In P19Cl6 
embryonal carcinoma cells, a pluripotent line that generates cardiac myocytes efficiently if 
treated with dimethylsulfoxide, a similar requirement for BMPs was shown. Transfecting noggin 
blocked differentiation and over-expressing Bmp2 or Smad1 plus Smad4 overrode the block 90, 
91. Forced expression of Nkx2-5 plus Gata4 could overcome noggin and re-enable cardiac 
differentiation in dimethylsulfoxide-treated cells, though insufficient to trigger the cardiac lineage 
in untreated cells 90. Noggin-inhibited genes identified in mESCs include more than a dozen 
cardiogenic transcription factors (Gata4/5/6, Hand1, Hod/Hop, Irx3/5, Isl1, Mef2c/d, Nkx2.5, 
Tbx20) 92. Earlier noggin-sensitive targets include key markers of mesoderm formation and 
patterning (Eomes, Evx1, Lhx1, Mesp1, Mixl1, Snail1, T/brachyury) along with other genes 
essential for cardiac development (Fgf8, the Nodal target Foxh1, and the Nodal co-receptor 
Tdgf1/Cripto) 92.  
Among these noggin-sensitive genes is Sox17, encoding an endoderm-associated 
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transcription factor that is expressed transiently in differentiating EBs. Sox17 was shown by 
RNA interference to be required for induction of Mesp1 and Mesp2 via a cell-nonautonomous 
mechanism—the earliest genes known thus far directing mesoderm towards a cardiac fate 93—
and for the later induction of cardiogenic transcription factors and cardiac structural genes 92. 
Induction of Sox17 by BMPs also was implicated in the differentiation of human ESCs (hESCs), 
the underlying mechanism being redeployment of Oct4 from the Sox2 to the Sox17 promoter 
when ESCs exit the pluripotent state 94. Over-expressing Oct4 promoted cardiogenic 
differentiation, which was reproduced by conditioned medium from Oct4-transfected cells, 
blocked by Sox17 shRNA, and blocked by neutralizing antibodies to BMP2. Expression of 
Sox17 and Mesp1/2 tended to be mutually exclusive, suggesting a paracrine basis for the 
latter’s dependence on Sox17 94. In addition to its direct induction of endodermal genes, Sox17 
may down-regulate genes for ESC pluripotency, through competition with Nanog 95. 
Of obvious importance towards producing human cardiomyocytes from stem cells under 
biochemically defined conditions, a cardiogenic effect of BMP2 or BMP4 in hESCs has been 
reported by many, usually in concert with Activin A 96, 97. A multi-stage protocol has been 
described entailing the sequential use of BMP4 alone, then BMP4 plus Activin A and FGF2 (to 
induce primitive streak-like cells and mesoderm, denoted by T and Wnt3a), followed by Dkk1 (to 
terminate the canonical Wnt signal and direct mesoderm into cardiac mesoderm) plus vascular 
endothelial growth factor and FGF2 (as mitogens) 98.  This series of steps efficiently induces 
KDRlow/C-KITneg multipotent cardiovascular progenitor cells that generate cardiomyocytes, 
smooth muscle and endothelial cells both in vitro and in vivo 98. Analogously, the identical multi-
step protocol 99 or the sequential administration of Activin A for 24 hr followed by BMP4 for 4 
days 100 directs cardiac myogenesis in human iPSCs.  
Given these highly concordant findings across a variety of model organisms and 
pluripotent stem cells, the few dichotomies are striking. Paradoxically, in view of the synergies 
between BMPs and FGFs discussed just above, BMP2 given with the FGF receptor inhibitor 
SU5402 induces multipotent cardiovascular progenitor cells denoted by stage-specific 
embryonic antigen-1, using hESCs, primate ESCs, or human iPSCs 101. As a provisional 
explanation, this discrepancy is more easily reconciled with the presence or absence of 
concomitant factors, rather than distinctions in the cell types used or produced. Other 
dichotomies are reconciled with timing. Whereas continuous exposure to noggin poses a barrier 
to cardiac myogenesis in mESCs and P19Cl6 cells, transient early treatment with noggin—from 
3 days before to one day after embryoid body formation—induces mesendoderm (T/brachyury) 
and subsequent cardiomyocytes, the latter increasing 100-fold 102. Likewise, gremlin, another 
extracellular BMP antagonist, enhances cardiomyogenesis in P19CL6 cells, inhibiting the 
inhibition by BMPs on days 1-3 103. As discussed below for the Wnt/β-catenin pathway, 
seemingly discordant actions are reconciled by the complex developmental sequence of events 
a given factor can control, promoting or suppressing production of cardiac myocytes as the net 
result. The adverse early effects of BMPs on cardiac myogenesis are likely ascribable to their 
role in promoting ESC self-renewal 104-107 and as suppressors of Wnt3a 103. Lastly, inherent 
differences between mESCs and hESCs in the control of pluripotency (the latter more closely 
resembling epiblast stem cells from mice in being independent of BMPs for self-renewal) may 
contribute to seeming discrepancies in the early response to BMPs and other factors 108.  
Progenitor/stem cells from post-natal hearts represent an interestingly different phase of 
maturation. Regardless of the markers used in their purification, these cells typically express 
most cardiogenic transcription factors but not (ordinarily) their targets, the cardiac structural 
genes 109, 110 111. Whereas this stage is just a transient intermediate in embryos and ESCs, it 
persists as a rare but durable phenotype in mouse and human adult hearts. In experiments to 
test for a role of BMP signals in the differentiation of mouse heart-derived progenitor cells, Cre-
 Circulation Research Manuscript #CIRCRESAHA/2010/223792 - R1 Review
Noseda, CIRCRESAHA/2010/223792 (revised) 
 11 
mediated deletion of Alk3 prevented the cells’ differentiation in culture 110.  
Cross-species comparisons 
• A requirement for BMPs in cardiogenesis is conserved in all species examined. 
• However, the timing is different in Xenopus, being required for differentiation but not 
specification. 
• Cellular sources of the BMP(s) also differ: endoderm in chick, ectoderm in flies, ventral 
trunk epidermis in Ciona. 
Activin and Nodal 
Pathway synopsis 
Activin and Nodal like BMPs are members of the TGFβ family but, unlike BMPs, signal 
via Smad2/3 not Smad1/5/8 as their receptor-regulated Smads 112 (Figure 1). These R-
Smad/Smad4 complexes promote cooperative DNA binding by the forkhead winged-helix 
protein FoxH1, which mediates many effects of the pathway. Nodal signals via an Activin type II 
receptor (ActRII or ActRIIB) together chiefly with the type I receptor ActRIB/Alk4 or Alk7. Activin 
itself signals through ActRII or ActRIIB, together with Alk4 or ActRIA/Alk2. Most Nodal effects 
require in addition a co-receptor of the EGF-CFC family, whose members are characterized by 
an Epidermal Growth Factor-like domain and include mammalian Cripto, Xenopus FRL-1, 
mammalian Cryptic, and zebrafish one-eyed pinhead 113. In a number of the experiments 
utilizing exogenous Activin to drive cardiac myogenesis, Activin may serve as a surrogate for an 
authentic Nodal signal. 
Avians 
Besides the ability of anterolateral endoderm to induce cardiac myogenesis in 
noncardiogenic mesoderm, ascribable to BMPs, a second region of avian embryos also 
possesses cardiogenic activity, the pregastrula hypoblast (the future extra-embryonic 
endoderm). Activin from this region promotes cardiac differentiation in posterior explants of the 
epiblast (the future three-germ-layer embryo), and induction by the hypoblast is blocked by 
follistatin 114, 115, a selective inhibitor of Activin binding. Interestingly, each growth factor can 
reprogram only explants from the normally neighboring region: Activin did not respecify 
noncardiogenic mesoderm, nor BMPs respecify the posterior epiblast. However, Activin may 
require BMPs as a downstream mediator, as its effect was suppressed by noggin 115. 
Conversely, early exposure to BMP2/4 before the mid-gastrula stage blocked the cardiogenic 
activity of Activin, resembling the aforementioned dichotomous effects of BMPs, depending on 
ESCs’ stage of development. 
Amphibians 
In Xenopus animal cap explants, Activin suffices to induce cardiac MyHC expression 116 
and beating cardiac tissue 117. The region of Xenopus endoderm that is necessary and sufficient 
for heart-inducing activity is noteworthy for expression of cerberus 1 (cer1) 118, encoding a 
multifunctional inhbitor of BMPs, Nodal, and Wnts that is sufficient to induce ectopic expression 
of nkx2-5 118, 119. In pluripotent ectodermal explant studies, Nodal proteins and FGFs were 
implicated as the cardiogenic activity of anterior endoderm, and gastrulation was pinpointed as 
the time for the Nodal requirement in cardiac induction 120. Nodal activity in the endoderm 
likewise was required for the cardiogenic effect of forcibly expressing the endodermal 
transcription factors sox7 plus sox18 121. Overexpressing nodal1 plus cripto induces early and 
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late markers of cardiogenesis in non-cardiac mesoderm (nkx2-5, tbx5, tnni3, myh6), with similar 
results for constitutively activated alk4 122. Both interventions acted via a cell-nonautonomous 
mechanism involving juxtacrine effects. Conversely, genetic disruption of cripto expression with 
antisense morpholino oligonucleotides blocked spontaneous heart induction in Xenopus 
embryos, as well as blocking cardiomyocyte differentiation driven by nodal1 plus cripto 122. Cer1 
was essential for Nodal-dependent cardiac specification, yet neither Cer-S (a fragment that 
selectively inhibits Nodal) nor a specific inhibitor of BMP receptors could stimulate heart 
induction. Hence, cardiac induction by cer1 may relate to its capacity as a Wnt inhibitor or, 
alternatively, as a dual inhibitor of Nodal plus BMPs 122. Certain other Xenopus nodal-related 
genes share with nodal1 the ability to induce cardiac mesoderm, e.g., nodal5 but not nodal6 123. 
Extrapolation to other species is problematic, as there are 6 nodal-related genes in Xenopus, 3 
in zebrafish and only one in mammals. 
Flies 
Although other features of cardiac myogenesis are well-conserved in Drosophila, there is 
no demonstrated role for Activin/Nodal signals. Despite extensive mutagenesis of the Activin 
orthologs (Actbeta, dawdle), type I receptor (baboon), and Smad2 equivalent (smox), the 
pathway is implicated, instead, in axon guidance 124.  
Fish 
In zebrafish, the nodal-related genes squint and cyclops have redundant functions in 
promoting mesoderm and endoderm formation, the double mutant altogether lacking both germ 
layers’ derivatives in the head and trunk, including the heart 125 (Figure 3). Mutations affecting 
the Nodal co-receptor, one-eyed pinhead, result in a partial reduction of Nodal signaling, and the 
mutant embryos show defects in cardiac specification and differentiation, especially in the 
ventricular chamber 35, 126. This strong dependence of the ventricular fate on Nodal signaling 
was also demonstrated by providing low levels of the extracellular Nodal antagonist, lefty1 127. 
Activin A was identified in an in vitro assay for the cardiogenic activity of conditioned medium, 
using dissociated cells from blastula-stage embryos of another genetically tractable fish, 
medaka, as the target 128.  
Mice 
Nodal is essential in early mouse embryos for positional information (establishing the 
anterior–posterior and left–right axes), gastrulation, forming the primitive streak, and hence the 
creation of mesoderm and endoderm, germ layer specification being a precondition for later 
cardiac myogenesis 129, 130. Cripto is likewise necessary for gastrulation and mesoderm 
formation, though a rudimentary anterior–posterior axis is formed 131, 132. Cripto-deficient mice, 
devoid of somites and cardiac tissue, altogether lack expression of Myh6, Myh7, Myl2, Myl7, 
and Nppa; hence Cripto, like Nodal, is obligatory if more specialized cardiac mesoderm is 
subsequently to appear. Cripto-independent Nodal signaling can be unmasked in mice lacking 
both Cripto and the Nodal antagonist Cerberus (Cer1): this combined mutation is partially 
rescued with regard to events controlled by Nodal, allowing survival of some embryos to mid-
gestation and even the creation of a rudimentary heart 133. Formation of the primitive streak and 
of mesoderm is crippled in mice with a combined deletion of both type II Activin receptors 134 or 
lacking either type I receptor, Acvr1/Alk2 or Acvr2/Alk4 66, 67, 135. However, ES cells lacking Alk2 
can contribute to the mesoderm, including heart tissue, if injected into wild-type blastocysts, and 
a role in extra-embryonic tissue likely accounts for the Alk2 requirement during gastrulation 66. 
The Activin/Nodal Smad partner Foxh1 is essential for development of the anterior heart field, 
interacting physically with Nkx2.5 to drive a Smad-responsive element controlling Mef2c 136.  
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Progenitor and stem cells 
Activin A has been used successfully together with other factors, especially BMPs, to 
induce cardiac myogenesis in mESCs 137, hESCs 97, 138, 139 and human iPSCs 100. The earliest 
genetic proof implicating Cripto in mammalian cardiac myogenesis was a demonstration in 
homozygous-null ESCs 140. Homozygous-null EBs lacked beating cardiomyocytes, cardiac 
proteins (sarcomeric MyHC, MLC2a), and cardiac mRNAs (Myl2, Nppa). Bypassing Cripto with 
constitutive active Alk4 or providing recombinant Cripto rescued the defect in null ESCs, and 
rescue by Cripto was suppressed by Cerberus or Cer-S, a truncation of Cerberus that 
selectively inhibits Nodal 141. In differentiating mouse embryoid bodies (EBs), the activating 
phosphorylation of Smad2 (signifying Activin, Nodal, or TGFβ function) is initially high but 
declines rapidly over the first few days, in parallel with down-regulation of Nodal and Cripto. The 
phosphorylation then rises on days 8-12 in parallel with Activin A and TGFβ. Blocking the early 
phosphorylation with a pharmacological inhibitor of ALK4/5/7 suppressed the induction of 
mesodermal and cardiac markers, promoting neuroectoderm instead. By contrast, blocking the 
late phase augmented cardiac differentiation, attributed to interference with 
TGFβ (reproduced by neutralizing antibodies or the type II receptor ectodomain) 142. Whereas 
Activin plus FGF2 maintains pluripotency in hESCs 143, the combined use of Activin, FGF2, 
BMP4 and vascular endothelial growth factor specifically promotes the formation of multipotent 
mesoderm-committed progenitor cells, able to generate all mesoderm cell types including 
cardiomyocytes, smooth muscle and endothelial cells 144. 
Cross-species comparisons 
• The requirement for Activin and Nodal in cardiogenesis is conserved in vertebrates but not 
flies. 
• A multiplicity of nodal-related genes in Xenopus subdivides the functions of the one nodal 
gene in mice. 
• Xenopus cer1 inhibits Nodal, Wnts, and BMPs, mouse Cer1 just Nodal and BMPs. 
Wnts, canonical and otherwise  
Pathway synopsis  
The Wingless-type MMTV integration site (Wnt) family takes its name from the 
Drosophila segment polarity gene wingless (wg) plus the mouse ortholog, int-1, an oncogene in 
mammary tumors activated by proviral insertion 145. The ligands (19 in the mouse and human 
genomes) act via seven-transmembrane-domain receptors of the Frizzled (Fz) family and the 
co-receptors low-density lipoprotein receptor-related protein (Lrp) 5 and 6 146-148 (Figure 1). So-
called “canonical” Wnts include Wnt1, -2a, -3a, and -8, this nomenclature denoting their 
requirement for signaling through β-catenin. In the absence of ligand, β-catenin is targeted for 
proteosomal degradation via its phosphorylation by glycogen synthase kinase 3β (GSK3β) and 
casein kinase 1 (CK1), in a destruction complex also including axin and the adenomatous 
polyposis coli (APC) tumour suppressor protein. Canonical Wnts cause the physical recruitment 
of the Disheveled protein kinase (Dvl, dsh) to the liganded Fz receptors, along with the 
destruction complex. These events lead to decreased phosphorylation of β-catenin, allowing 
stabilization, cytoplasmic accumulation, and eventual nuclear translocation of the protein 149. 
Nuclear β-catenin in turn serves as a co-activator for T cell-specific transcription factor/ lymphoid 
enhancer-binding factor 1 (Tcf/Lef) proteins, displacing Groucho/Transducin-Like Enhancer co-
repressors and recruiting further co-activators 150. Broad-spectrum inhibitors of Wnt signaling 
include secreted Frizzled-related proteins (sFRPs, FrzB, Crescent) and the Fz ectodomain. 
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Inhibitors specific for canonical Wnts include the extracellular protein Dickkopf (Dkk) and 
constitutively active GSK-3β. Some ostensible Wnt inhibitors, FrzB and Crescent, paradoxically 
extend the range of Wnt signals, by facilitating diffusion of the ligands 151.  
β-catenin-independent (“noncanonical”) Wnts like Wnt4, -5a and -11 trigger two main 
signaling cascades. One branch, the planar cell polarity pathway, entails the G-proteins Rho 
and Rac activating Rho-associated protein kinase (ROCK) and Jun N-terminal kinase (JNK) 
respectively. The second depends on phospholipase C (PLC), with ensuing Ca2+ release 
activating protein kinase C (PKC) and calmodulin-dependent protein kinases (CaMKs).  
As newly uncovered complexities within this system, Dvl is implicated in all three Wnt 
pathways 152, alternative Wnt receptors include two transmembrane tyrosine kinases, Ryk and 
Ror2 153, noncanonical Wnts can inhibit canonical Wnt signals 154, and “noncanonical” Wnts can 
act through the canonical pathway, depending on receptor context 154, 155. 
Avians 
In avian embryos, cardiogenic mesoderm formation depends on signals from anterior 
endoderm including BMPs, yet the competence of mesoderm to respond is spatially restricted 
and some cardiac genes are not induced by BMPs alone 21, 156. This prompted a search for 
complementary signals, ultimately unmasking a role for Wnts quite different from the findings for 
wg in flies. Posterior non-cardiomyogenic mesoderm was induced to express cardiac genes 
when co-cultured with anterior endoderm, a tissue expressing the Wnt inhibitor Crescent 157. 
Crescent, like Dkk1, suffices to induce cardiomyogenesis in hematogenic posterior mesoderm 
157. Over-expressing Wnt3a and Wnt8c in mesoderm explants or the precardiac mesoderm in 
vivo inhibits cardiomyocyte differentiation and redirects mesoderm to express ρ-globin, a marker 
of primitive erythrocytes. The relevant source of inhibitory Wnts in the embryo is the neural tube, 
its Wnt1 or Wnt3a ordinarily preventing cardiogenesis in the adjacent anterior paraxial 
mesoderm. Ectopic cardiogenesis is induced in this region by a FrzB fusion protein, another 
extracellular Wnt inhibitor 158. Combined, these expression patterns confer an anterio-posterior 
gradient of Wnt signaling, lowest in the anterior (cardiogenic) mesoderm and highest in the 
posterior (blood-forming) mesoderm, intersecting an orthogonal gradient of BMP activity along 
the dorsal-ventral axis 157, 158. Hence, Wnt/β-catenin signals oppose cardiac myogenesis in 
avians,  
Notably, dichotomous results emerged for the noncanonical pathway. Anterior 
expression of endogenous Wnt11 is localized to the precardiac mesoderm, and effects of Wnt11 
in a quail mesodermal cell line suggested a role in cardiac myogenesis 159. Wnt11 plasmids and 
Wnt11-conditioned medium induce ectopic cardiac differentiation, in quail posterior mesoderm 
160.  
Amphibians 
During Xenopus gastrulation, Wnt/β-catenin ligands impair heart specification 161-164, and 
later activation of the pathway impairs cardiac myocyte differentiation 120. Conversely, inhibiting 
the Wnt/β-catenin pathway with dkk1 and crescent (inhibitors expressed by the Spemann 
organizer), gsk3b, or dominant-negative tcf3 confers the induction of cardiac genes and beating 
cardiomyocytes in non-cardiogenic mesoderm 162, 164. Much like the nodal/alk4/cerberus 
pathway, this Wnt/β-catenin effect involves an endodermally expressed gene (in this case, the 
transcription factor hex) and a diffusible signal for mesoderm patterning toward the cardiac 
muscle fate 122, 162. The canonical Wnts 3a and 8 blocked cardiomyogenesis in dorsal marginal 
zone mesoderm explants, while the noncanonical Wnts 5a and 11 did not 164.  
Indeed, Wnt11, which is selectively expressed in cardiogenic mesoderm, is required for 
heart formation in Xenopus embryos: dominant-negative wnt11 and wnt11 morpholinos strongly 
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down-regulate nkx2-5 and cardiac troponin I (tnni3) throughout the heart field 165. Conversely, in 
isolated animal caps, wnt11 induced gata4, gata6, nkx2-5, myh6, and tnni3, whereas dominant-
negative Wnt11 interfered with Activin-induced cardiac myogenesis 165. The presently available 
data are inconclusive about the respective role played by the planar cell polarity and 
PLC/calcium-dependent pathways, with PKC and JNK both implicated, but not CaMKII 165. 
Flies 
In Drosophila the prototypical Wnt gene wg is essential for cardiogenesis and 
collaborates with the BMP ortholog, dpp, to specify the heart tube in flies 166-169. Overexpressing 
disheveled (dsh) can restore cardiogenesis in the absence of wg 167 and increases heart 
precursor numbers 166. Notably, wg drives cardiac myogenesis via the canonical Wnt pathway, 
its essential downstream mediators in addition to dsh being the β-catenin ortholog armadillo and 
the Tcf/Lef ortholog pangolin 166-168. Less clear is the role for shaggy/zeste white 3, the GSK-3β 
ortholog 167. Shaggy opposes the cardiogenic wg pathway—as expected from its epistatic 
relationship to armadillo and pangolin—but also promotes formation of a larger "dorsal 
mesoderm,” the common substrate for cardiogenesis and visceral mesoderm induction by 
tinman and dpp 168.  
Fish 
In zebrafish, the Wnt/β-catenin signaling pathway plays temporally distinct roles in 
cardiac myogenesis, promoting heart formation before gastrulation yet inhibiting it at later 
stages 170 (Figure 3). Activation of Wnt/β-catenin signaling at pre-gastrula stages (up to 5 hours 
post fertilization) increases nkx2.5 expression, whereas activation during gastrulation (6 to 9 
hours post fertilization) inhibits its expression. These reciprocal phenotypes were inferred using 
heat shock-inducible transgenic embryos to overexpress the Wnt/β-catenin antagonist, dkk1, at 
precise times 170. Remarkably, the switch between promoting and suppressing 
cardiomyogenesis takes place within just one hour of zebrafish development 170. Analogously, 
knocking down plakoglobin—a related member of the catenin family of cell adhesion proteins—
increased the expression of proven Wnt/β-catenin targets (bozozok, bmp4, and the artificial TCF 
reporter TOPdGFP), reduced the expression of cardiac genes (nkx2-5, cmlc2, vmhc) and 
reduced the number of cardiac precursors, indicating a role in restricting Wnt/β-catenin signaling 
during gastrulation, but not earlier 171. Conversely, dkk1 suffices to rescue the plakoglobin 
morphant.  
These results help explain earlier findings that hyperproliferation of cardiac progenitors 
results from an increased reptin/pontin ratio, involving two proteins of the AAA+ (ATPase 
Associated with diverse cellular Activities) family. Reptin and pontin are recruited to β-
catenin/Tcf and respectively suppress or potentiate β-catenin-dependent genes 172. Knocking 
down β-catenin markedly augments the reptin gain-of-function phenotype. However, the precise 
stage of development is not known at which reptin, pontin, and plakoglobin impinge on 
canonical Wnt signals governing cardiac myogenesis.  
By contrast, to date there is no evidence for an effect of noncanonical Wnts on the heart-
forming field in zebrafish, interference with the pathway causing impaired midline migration of 
heart precursor cells (cardia bifida), not impaired lineage decisions 170, 173. It is unknown if this 
difference from chicks and frogs might reflect the presence of a SHF in those species but none 
so far in zebrafish 174.   
Mice 
Relevant manipulations of the Wnt/β-catenin pathway in mice include deleting β-catenin 
at the egg cylinder stage—in visceral endoderm, anterior primitive streak, node, notochord, and 
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definitive endoderm—using cytokeratin 19-Cre, which, remarkably, provoked the formation of 
multiple hearts along the anterior-posterior axis of the embryo 175. Theoretical explanations 
include a change of endodermal fate, failure of precardiac mesoderm to migrate normally, and a 
third, favored by results in chimeric mice, the loss of a normal constraint on endodermal signals 
that specify cardiac mesoderm 175.  
Cre-dependent expression of stable β-catenin in Isl1-determined cells, including the 
SHF, caused right ventricular enlargement and hyperplasia; conversely, ablating β-catenin in 
this lineage causes failure of right ventricular development 176-178. Similar results occurred using 
Mef2c-AHF-Cre 178, 179 (driven by the AHF-specific Mef2c enhancer), SM22α-Cre 180, or Mesp1-
Cre 83, the latter two preferentially affecting the SHF perhaps because β-catenin regulates Isl1 
itself 177. Under these conditions, the pathway’s predominant effect was enhancing 
cardiomyocyte proliferation, inducing cyclin D2 via the transcription factor Pitx2 181. Cardiac 
hypoplasia likewise resulted from deleting Gsk3b, and the induction of cardiac structural genes 
was markedly impaired in ESCs lacking the kinase 182. However, a caveat is raised by the 
absence of change in β-catenin levels or localization, suggesting a β-catenin-independent 
mechanism as responsible 182. Outflow tract anomalies also result from mutations of Wnt5a, 
Dvl2, Dvl3, and Vangl2, a component of the planar cell polarity pathway, but the state of cardiac 
gene expression in these models is not established 183-185.  
Wnt2 and Wnt11 offer the most persuasive connections to cardiac gene expression in 
mice. Wnt2 is expressed specifically in the posterior developing heart, and Wnt2-/- mice show 
hypoplastic atria with defective sarcomeres and decreased cardiac gene expression (Gata6, 
cTnI) 186. Wnt11 is also required for mouse cardiac development, the most obvious roles being 
in morphogenesis of the ouflow tract 187 and ventricular walls, including deficient expression of 
Gata4, Mef2c, Nkx2-5 and Nppa 188.  
Progenitor and stem cells 
Evidence that canonical Wnt signaling is required for mammalian cardiomyocyte 
formation by pluripotent cells was first obtained in P19CL6 embryonic carcinoma cells 189 and 
substantiated later in ESCs 92, 170, 176, 190, 191. In P19 cells dimethylsulfoxide-induced differentiation 
recapitulates the early steps of cardiac specification. Wnt3A, Wnt8A, biochemical mediators of 
Wnt signaling (hypophosphorylation and increased abundance of β-catenin) and TCF-
dependent reporter activity were induced days before even the earliest cardiogenic transcription 
factors. The induction of cardiogenic transcription factors, cardiogenic growth factors, and 
sarcomeric MyHC was blocked by the Wnt inhibitor Frz8/Fc or constitutively active GSK-3β 189. 
Conversely, cardiac myogenesis (Nkx2-5, Gata4, Mef2c, Tbx5, Myh6) was enhanced by Wnt3A-
conditioned medium or by lithium, a GSK-3β inhibitor. Comparable results were obtained by 
manipulations of the secreted Wnt inhibitor SFRP2 192.  
This obligatory role for Wnt/β-catenin—seemingly dichotomous with the suppression of 
heart formation in avians and amphibians—was found to hold true in mouse ES cells as well as 
in zebrafish. Rather than mere phylogenetic differences, this was ultimately attributable to the 
stage of differentiation captured in each model. In short, the Wnt/β-catenin pathway is essential 
for mesoderm and endoderm formation by pluripotent cells 92, 170, 176, 190, 191, yet inhibits cardiac 
myogenesis once mesoderm has been created 170, 191. Early Dkk-sensitive genes in 
differentiating mESCs include pivotal regulators of mesoderm formation (T, Eomes) and 
mesoderm patterning toward a cardiac fate (Cripto, Mesp1) 92. The loss of Wnt//β-catenin 
signals using Dkk1 in the first four days blocked induction of primitive streak- (T, Mixl1, Evx1), 
mesendoderm- (Gsc, Sox17, Foxa2) and mesoderm-associated genes (Mesp1, Nrp1, Pdgfra), 
as well as later cardiac (Gata4, Tbx5, Nkx2-5) and hematopoietic (Gata1, Tal1) mesoderm 
derivatives 190.  
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Like BMP and Nodal, canonical Wnts are required to induce Sox17 and hence confer the 
Sox17-dependent mechanisms that direct primitive mesoderm to a cardiac fate, including Hex 
and Wnt11 92. Even providing Dkk1 at the time of peak Mesp1 expression drastically reduces 
cardiac differentiation in EBs 62. By contrast, stimulating the Wnt/β-catenin pathway later than 
day 5 with Wnt3A or 6-bromoindirubin-3’-oxime, a GSK-3β  inhibitor, suppressed cardiomyocyte 
differentiation 170, 191. Similarly, insulin-like growth-factor-binding protein-4, a newly identified 
suppressor of the Wnt/β-catenin pathway, blocks cardiac myogenesis in mESCs if given on 
days 0-3 but enhances it if given subsequently 193. The ability of Mesp1 to promote cardiac 
specification in mesoderm is reportedly dependent on its induction of Dkk1 at this stage 194. In 
related studies, forced expression of Mesp1 in ESCs could induce many cardiogenic 
transcription factors (Foxc1/2, Gata4/6, Hand1/2, Isl1, Myocd, Smyd1, Tbx5/20), yet high-level 
expression of Nkx2-5 and the induction of cardiac structural genes specifically required 
supplementation of Dkk1 61; cf. 62. 
The temporally distinct effects of Wnts that impinge on cardiac myogenesis in stem cells 
and native development are dramatic and unquestioned, yet unexplained in molecular or 
network-level terms. Mechanistically, there are three overall possibilities. First, these stage-
dependent effects of exogenous Wnts could potentially be attributable to developmental 
changes in Frz, other components of the Wnt signaling machinery, or endogenous Wnts’ 
expression. As mentioned, in mouse ESCs, the induction of Wnt11 occurs subsequent to and 
contingent on the β-catenin-dependent induction of Sox17 92. Many other temporal changes 
occur in Wnt receptors and inhibitors, whose functional significance has not been determined. 
Second, independent of any change in the Wnt pathway itself, temporally distinct effects of 
canonical Wnts on target genes could occur as a consequence of the concurrent inputs to those 
genes, including but not limited to other growth factor cascades. A third possibility is suggested 
by the precise temporal control of several essential canonical Wnt targets including T and 
Sox17, which might impair normal mesoderm patterning if their expression were prolonged.  
Though the precise mechanism for this late suppressive effect of canonical Wnts on 
cardiac specification is not known, it is associated with redirecting Flk+ mesoderm to a 
hematopoietic fate 195. Indeed, endogenous canonical Wnts also are critical for cardiogenic 
differentiation in hESCs, cardiogenesis being blocked by Dkk-194, and the effect is biphasic, as 
in mESCs. With respect to adult human cells, cardiac differentiation is enhanced in endothelial 
progenitor cells (EPCs) by the noncanonical Wnts 5a and 11, working via PKCδ 196, 197. Human 
circulating mesoangioblasts, which already express Isl1, Gata4, Mef2c and Tbx5, undergo 
cardiac differentiation when treated with Wnt3a 198.  
Cross-species comparisons 
• Canonical Wnt/β-catenin signals are required for cardiogenesis in flies. 
• In vertebrates, before gastrulation, canonical Wnt/β-catenin signals have essential but 
indirect roles in cardiogenesis, involving the induction of primitive mesoderm plus the 
endoderm needed for mesoderm patterning. 
• After gastrulation, canonical Wnt/β-catenin signals are inhibitory in vertebrates (avian, 
amphibian, fish and mice).  
• Cardiopoietic effects of non-canonical Wnts after gastrulation are conserved in all tested 
vertebrates except fish. 
• This complex temporal sequence is recapitulated in both mouse and human ESCs. 
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Fibroblast growth factors 
Pathway synopsis 
The highly conserved FGF pathway entails, in mammals, approximately 20 ligands and 
four transmembrane receptor tyrosine kinases (FGFRs) 199, 200 (Figure 1). FGFs act in autocrine 
and paracrine loops, are sequestered but also stabilized by heparan sulphate proteoglycans, 
and require enzymatic release from the extracellular matrix. Ligand binding results in receptor 
dimerization, then autophopshorylation in trans on cytoplasmic tyrosine residues, which become 
docking sites for adaptor proteins and downstream mediators 200. To illustrate three relevant 
pathways: the adaptor Fgfr substrate 2 (Frs2) allows recruitment of Grb2 and Sos, triggering the 
Ras/Raf/MEK/ERK mitogen-activated protein kinase (MAPK) pathway; Grb2-associated binding 
protein 1 (Gab1) activates the phosphatidylinositol-3-kinase (PI3K)/Akt pathway; and binding 
phospholipase C (PLC) γ catalyzes the hydrolysis of phosphatidylinositol 4,5-bisphosphate to 
inositol trisphosphate and diacylglycerol, leading to intracellular calcium release and PKC 
activation.  
Avians 
Studies of chick embryos in the early 1990s suggested that FGFs have several autocrine 
and/or paracrine functions in early cardiogenesis 201-203. One role was uncovered using 
antisense oligonucleotides to FGF2 or neutralizing antibodies to FGFR1, which blocked cardiac 
precursors’ proliferation 202, 204. Gain-of-function experiments deploying the ligands, however, 
showed an instructive cardiogenic effect. FGF2 induces cardiac actin and spontaneous 
contractions in explants of anterior lateral mesoderm 203. Ectopic delivery of FGF8 (the ligand 
expressed in endoderm adjacent to precardiac mesoderm) promotes lateral expansion of the 
heart field and ectopic expression of Nkx2-5 and Mef2c, but not Gata4 205. Likewise, exogenous 
FGF8 can rescue Nkx2-5 in embryos whose endoderm was ablated. This robust although partial 
effect may help explain the synergies obtained when FGF4 is given with BMPs 115, 206, 207 (though 
contradicting results with SU5402), as well as the restriction of heart field expansion by FGF8 
just to regions of BMP activity 205.  
Importantly, a combined genomic and systems biology strategy has clarified the interplay 
of BMP and FGF signaling in development of the avian SHF: the abililty of BMP4 to promote 
cardiac gene expression (myomesin, titin) and induce beating heart tissue hinges on its 
inhibition of endogenous FGFs (FGF3, -8, -18, -19), which otherwise keep the cardiac 
progenitor cells of the SHF in a proliferative undifferentiated state 29. Of the many pathways 
downstream from FGF receptors, ERK was responsible. Induction of myofibrillogenesis by 
BMPs was mediated by the neural crest-related gene MSX1, which in turn suppresses FGFs, 
blocks cell proliferation and mimics the BMP effect on sarcomeric gene expression 29. Under 
these conditions, FGFs act subsequent to cardiac specification and have minimal effect on 
cardiogenic transcription factors (GATA4, TBX20). 
Amphibians 
In contrast to the range of studies performed in other species, the role of FGFs in 
Xenopus cardiac development has been explored less. Nevertheless, using an assay whereby 
pluripotent presumptive ectodermal explants are induced to form cardiac muscle by anterior 
endoderm, a requirement for FGF signaling has been confirmed 120. 
Flies 
A Drosophila ortholog of FGF receptors with the self-explanatory name of heartless (htl), 
one of two FGF receptor genes in flies, is specifically expressed in presumptive mesoderm and 
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essential for creating the dorsal vessel 208-210. Both htl and its effector heartbroken, which 
couples the receptor to MAPK signaling, are required partly for cardiac precursors’ migration to 
the dpp-expressing domain (rather than their competence to respond to dpp), although a role in 
specification also exists 208-211. In addition, dpp and wg contribute to the definition of mesodermal 
cell clusters that give rise to cardiac progenitors, by activating htl and the Drosophila epidermal 
growth factor receptor 211-213, and by controlling the expression of Ras pathway effectors for the 
receptor tyrosine kinases 213, 214. Two redundant FGF genes, pyramus and thisbe, members of 
the Fgf8/Fgf17/Fgf18 sub-family, encode the essential ligands for htl, their combined deletion 
causing defects similar to those in htl mutants, including abnormal mesoderm migration and the 
loss of cardiogenesis 215. 
Fish 
In zebrafish, the fgf8/ace mutant exhibits a strong reduction in early stages of heart 
development, with particular effect in the ventricle, although some recovery is seen later in 
development 216, 217 (Figure 3). Fgf8 mutants have reduced levels of Nkx2-5, but normal levels of 
Gata6 217, consistent with the preferential effect of FGF8 in avians 205. Simultaneous knockdown 
of the FGF/Ras/MAPK signaling mediators, etv5, erm and pea3, gives a similar phenotype to 
the one observed in ace mutants 218. Inhibition of FGF signaling using a pan-FGF receptor 
inhibitor, SU5402, shows an even greater loss, suggesting the involvement of additional FGF 
effectors 217, 219. Recent work has shown that regulation of heart size at early stages of 
embryonic development is made in close spatial and temporal association with the anterior 
blood and endothelial populations, where FGFs play a critical role in determining the fate of the 
anterior lateral plate mesoderm (F. Simões, T. Peterkin, and R. Patient, unpublished data, 
2010). These observations have implications for the derivation of cardiomyocytes from 
pluripotent cells and suggest a model for how expansion of the heart field may have occurred 
during the course of evolution. Later requirements for FGFs in zebrafish have also been 
revealed: beyond the initial regulation of heart size, FGF signaling is important for ventricular 
maintenance and later differentiation of cardiomyocytes in the arterial pole 219, 220. Analogously, a 
chemical genomics screen revealed that a small molecule antagonist of dual specificity 
phosphatase 6 (Dusp6)— a feedback inhibitor of FGF signaling—causes expansion of the heart 
field (nkx2-5-, gata4-, and hand2-expressing cells) and subsequent heart size 221.  
Ciona 
Ciona expresses a single FGF receptor and six FGF ligands 222. FGF signaling 
participates in cardiac specification by acting on Mesp-positive cells that define the precardiac 
mesoderm and co-express Ets1/2, a transcriptional effector of RTKs 57, 223, 224. Whereas a 
dominant-negative FGFR and dominant-negative Ets1/2 block cardiogenesis, FGF delivery and 
constitutively active Ets1/2 induce not only expansion of the cardiac progenitors, but also the 
formation of a double-chambered heart in lieu of the normal U-shaped tube 223, 224. Hence, an 
FGF/RTK/Ets1/2 module participates in cardiac specification and can even drive a more highly 
evolved chamber geometry, as in zebrafish. Fgf9/16/20 was postulated as providing the ligand, 
since it is expressed in the right spatio-temporal pattern 58. In a systematic gene disruption 
approach to study dozens of regulators in Ciona, Fgf9/16/20 was identified as a β-catenin target 
that functions together with Tbx6 to activate Mesp 57, 58. The forkhead transcription factor FoxF, 
a direct target of Ets1/2, is required for the migration of cardiac progenitors to allow the correct 
anatomical location of the heart, though not for cardiac specification 225, 226. 
Mice 
Fgf8 expression in mice suggests a role in cardiac development, and comprehensive 
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studies of conditional and hypomophic alleles confirm that Fgf8 is crucial for the development of 
the SHF. This includes a requirement for Fgf8 in pharyngeal endoderm for outflow tract 
septation and in mesoderm for precisely aligning the outflow tract and ventricles 227, 228. At the 
cellular level, Fgf8 controls proliferation, survival and the expression of cardiac transcription 
factors like Isl1 and its target Mef2c 228. Fgf9 and its relatives Fgf16 and Fgf20 are expressed in 
both endocardium and epicardium at mid-gestation and contribute to myocardial proliferation 229. 
Fgf9 is induced by retinoic acid (RA), which was known to control the production of unidentified 
epicardial mitogens, and its deletion causes ventricular hypoplasia. Conditional loss-of-function 
studies using Mlc2v-Cre to delete Fgfr1 and Fgfr2 evoke a more severe defect, implicating other 
Fgfs beyond just Fgf9, either receptor singly being sufficient for a normal heart phenotype 229. As 
predicted, FGF16 and FGF20 delivered on heparin beads can promote cardiomyocyte 
proliferation in organ culture. Increased levels of sarcomeric actin in Fgf9-/- and receptor-
deficient hearts suggest a role for FGFs in the balance of proliferation and differentiation during 
cardiomyogenesis. However, an acknowledged limitation of the conditional Cre strategy was 
deleting the genes only after cardiac specification had transpired, preventing the capacity to 
detect effects impinging on this lineage decision. It is unknown whether cardiac fibroblasts, a 
potential source of FGFs, ever play an instructive role akin to their known function as a source 
of cardiomyocyte mitogens in the embryo and hypertrophic factors in the adult 230. 
Progenitor and stem cells 
Of interest to protocols for improving cardiomyocyte production from hESCs, inhibition of 
FGF signaling by the compound SU5402 markedly augmented BMP2-dependent cardiogenic 
specification, demonstrated by a 3-10 fold further induction of mesodermal and cardiac markers 
96, though contradicting the enhancement by FGFs under other conditions. Indeed, in mESCs, 
loss of Fgf4 or inhibiting FGFR signals adversely blocks the normal response to BMPs, 
impairing mesoderm differentiation 231, disparities that could be contingent on species, stage or 
exact ligands. FGF signaling also has a demonstrated role in the differentiation of adult cardiac 
progenitors. In vitro differentiation of cardiac Sca-1+ cells into beating cardiomyocytes was 
defective in Fgf2-null mice and rescued by exogenous FGF2 232. Interestingly, proliferation was 
not affected, arguing against mere density-dependent community effect as the explanation. In 
cell grafting experiments, the homing, engraftment and differentiation of cardiac Sca-1+ cells 
given intravenously required Fgf2 either in the donor cells or in the host 232, suggesting a 
possible benefit of FGF2 in cell therapy for cardiac disease if confounding effects on other cell 
types can be avoided.   
Cross-species comparisons 
• A requirement for FGFs in cardiogenesis is conserved. 
• However, the role in proliferation seen in avians, Ciona and mice is not conserved in fish 
(may be stage-dependent). 
Notch 
Pathway synopsis 
Notch signaling differs in key respects from that for the TGFβ family (receptor 
serine/threonine kinases), Wnts (serpentine receptors), and FGFs (receptor tyrosine kinases) 233 
(Figure 1). Notch proteins are single-span transmembrane receptors, four in mammals. Their 
ligands are transmembrane proteins on the surface of adjacent cells, the Delta-like (Dll, Dlk) and 
Jagged (Jag)/serrate families. Ligand binding triggers Notch cleavage by the γ-secretase 
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complex and a disintegrin and metalloproteinase (ADAM) proteins, releasing the Notch 
intracellular domain (NICD) for nuclear translocation. Once nuclear, the NICD binds, de-
represses and activates CSL transcriptional regulators (CBF1/recombination signal binding 
protein for immunoglobulin kappa J region [Rbpj], Suppressor of Hairless, Lag1), dislocating co-
repressors (Groucho, SMRT/NCor2, histone deacetylases) and recruiting co-activators 
(Mastermind‑like [MAML], histone acetyltransferases [p300/CBP]) 233. The newly active 
transcription complex drives expression of Notch target genes including basic-helix-loop-helix 
Hes/Hey transcription factors that are important to chamber specification and demarcating the 
atrioventricular canal from surrounding chamber myocardium 234. Notch commonly regulates cell 
fate by the mechanism of lateral inhibition (Equivalent cells cross-inhibit each other, so that 
changes in one prevent the neighbor from the same.) and asymmetric cell division (Of the two 
paired daughter cells, one will contain a repressor of Notch such as Numb, which targets the 
NICD for degradation.) 235. As the NICD interacts physically with both Smad and Dvl proteins, 
direct cross-talk exists with TGFβ family and Wnt cascades 236, 237. 
Avians 
Constitutive activation of Notch and dominant-negative RBPJ both block cardiac muscle 
differentiation in chick embryos, while increasing the expression of conduction system markers 
238. Likewise, a Notch2 pathway regulates Hey1-dependent down-regulation of Bmp2, delimiting 
chamber from non-chanber myocardium in the AV canal 239. 
Amphibians 
Work in Xenopus provided evidence that serrate and notch suppress cardiogenesis 240. 
However, while activation of the Notch pathway diminished myocardial gene expression, this 
manipulation was not performed until after cardiac specification had occurred. Further 
investigation of a role for notch earlier in development revealed a role during gastrulation 241, 242. 
Activating notch during gastrulation reduced the cardiac field and suppressing notch had the 
opposite effect 241. However, a broad role in boundary formation between the endoderm and 
mesoderm was proposed. Therefore, to determine the role of notch during cardiac specification, 
a complex regime of temporally inducible notch constructs to activate and suppress the pathway 
sequentially was used 242. Enhancement of Notch signaling during gastrulation results in 
ablation of nkx2-5 expression at the tailbud stages. Augmenting the signal in a window of 
development from stage 10-16 was crucial for this effect: if the length of treatment was reduced 
to stages 10-14, nkx2-5 was no longer down regulated. In contrast, suppression of notch during 
gastrulation causes premature expression of nkx2-5 in gastrula embryos. Over-expression of 
notch down-regulates endogenous gata4, but exogenous hormone-inducible gata4 in turn can 
rescue the mispatterned heart field when notch signaling is activated. Thus, notch appears to 
regulate the timing of heart field specification in Xenopus. 
Drosophila 
The Drosophila genome encodes one Notch receptor (N) and two ligands (delta and 
serrate). Developing mesoderm expresses notch 243, which has critical roles in mesodermal 
progenitor cells 244-246. Lack of notch causes a four-fold expansion of cardioblast numbers 247, as 
did loss of the ADAM10 ortholog kuzbanian 248. Conversely, the NICD inhibits heart formation, 
maintaining mesodermal progenitors in an uncommitted state 249, 250. Mesodermal patterning by 
notch involves the control of lateral inhibition, whereby initially equivalent tinman-expressing 
precursors give rise to cardiac muscle, pericardial cells, and DA1 dorsal muscle. Experiments 
using activated notch, loss of the notch inhibitor numb, and numb over-expression show that 
numb-dependent interference with notch is required in one of the two daughter cells, to create 
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the pericardial versus myocardial derivatives 251-254. Notch also controls the Drosophila 
equivalent of mammalian hemangioblasts, which gives rise alternatively to cardioblasts or 
hematopoietic lymph-gland cells. In this context, notch antagonizes tinman and pannier, 
inhibiting cardioblast formation, while inducing the hematpoietic GATA factor serpent and the 
development of lymph-gland progenitors 254, 255. Notch signaling is regulated at least in part 
through the highly conserved microRNA dmiR-1, which inhibits translation of delta and is 
essential for control of cardioblast number 256.  
Fish 
The role of Notch signaling in cardiogenesis has not been studied as thoroughly in 
zebrafish as in other model organisms. However, mutation of the Notch target gene gridlock (the 
Hey2 orthologue) causes expansion of Bmp4 in the atrioventricular canal and inner curvature of 
the heart 239. Because Bmp4 in zebrafish is a marker of the atrioventricular canal, these findings 
resemble the role of Notch in delimiting non-chamber myocardium in other species. 
Mice  
Many loss-of-function phenotypes support Notch as having a role in development of the 
mouse heart, such as impaired trabeculation from the lack of Notch1 257, Rbpj 257, 258, or Hey1 
plus Hey2 259, myocardial hypoplasia in mice homozygous for hypomorphic Notch2 260, and right 
ventricular hypoplasia from the combination of hypomorphic Notch2 and hemizygosity for 
Jagged 261. However, effects of Notch on the placenta, yolk sac, and embryonic vasculature as 
well as the heart raise barriers to inferring a direct role of Notch on cardiac myogenesis. 
Myocardial-specific loss of Hey2 causes atrialization of the ventricles (Sln, Myl4, Myl7), 
suggesting that Hey2, which is normally expressed in just the ventricle, mediates chamber 
specification 262. Trabeculation requires signals from adjacent endocardium, and a role for Notch 
in the endocardium was shown using Tie2-Cre to delete Notch1 and Rbpj, revealing that Notch 
acts upstream of three endocardial signals for trabeculation, Neuregulin, EphrinB2, and Bmp10 
257. Conversely, deleting Notch in cardiomyocytes with Myl2-Cre did not perturb heart 
development, though up-regulating Gata4, Nkx2-5, and Myh6 263. Deleting Notch with Isl1-Cre 
prevented formation of the right ventricle and markedly impaired the expression of Isl1, as well 
as two other essential cardiogenic transcription factors, Myocd and Smyd1 264. Hence, the 
requirement for Notch in the SHF is limited to an interval before cardiac differentiation occurs. 
This Notch loss-of-function resembles the effect of stabilized β-catenin in the SHF and was 
shown to increase nuclear β-catenin in that region of the embryo 264.  
Progenitor and stem cells 
As the effects of Notch signaling are highly context-dependent, several informative 
manipulations of Notch in differentiating stem cells take advantage of conditional expression at 
precise stages. Engineered in mESCs as an estrogen receptor fusion protein for tamoxifen-
dependent nuclear translocation, Notch activated at the time of mesoderm differentiation inhibits 
many derivatives, including Flk1+ multipotent cardiovascular progenitors 265. Rbpj appears 
responsible, given a robust increase of cardiomyogenic colonies using mESCs lacking Rbpj 265, 
266. Others confirmed that Notch inhibits cardiac myogenesis in ESCs, favoring neuroectodermal 
development instead 267, 268. Thus, down-regulating the Notch pathway would appear well-posed 
as a means to augment cardiac myocyte creation by ESCs.  
Confounding this simple extrapolation, a tetracycline-inducible system to express 
constitutively activated Notch4 or Notch1 in brachyury-GFP+/Flk1+ hemangioblasts derived from 
mESCs was shown to respecify hemangioblasts efficiently to a cardiac fate, yielding populations 
containing >60% cardiomyocytes. This cardiogenic effect of Notch was transient, confined to the 
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hemangioblast window, and targeted to blast colony-forming cells. Activated Notch4 induced 
many cardiogenic transcription factors (Nkx2.5, Isl1, Tbx5, Tbx20), along with BMPs (-2, -6, -7), 
Wnt2, Wnt4 (a β-catenin-independent Wnt), and Wnt inhibitors Sfrp 1 and 5 269. The addition of 
Wnt3a to the Notch4-activated brachyury-GFP+/Flk1+ cells prevented cardiogenesis, measured 
by cTnT staining, and the combination of sFRP1, Wnt5a and BMP6 was capable of inducing a 
prevalence of roughly 50% cardiomyocytes, if administered to day 3-3.25 brachyury-GFP+/Flk1- 
cardiac mesoderm269. Given to infarcted mice, these Notch4-activated cells generate more 
cardiac muscle in vivo than control cells and a greater benefit to cardiac pump function 270. As 
these cardiogenic effects resemble the findings in Rpbj-deficient ESCs, it was surmised that 
Notch might activate cardiogenesis via mechanisms independent of Rbpj, such as its known 
interaction with Smads 236, 271 or Dvl 237. 
Most neonatal mouse cardiac progenitor cells expressing c-kit co-express Notch1, and in 
these cells immobilized Jagged-1 or the NICD induces Nkx2-5, possibly by direct binding of 
Rbpj to the Nkx2-5 promoter 272. However, later markers were not analyzed and the extent of 
differentiation is unclear. Human circulating progenitor cells’ expression of α-sarcomeric actinin 
and TNNT2 (induced by co-culture with rat cardiomyocytes) is associated with Notch activation 
and blocked by preventing Notch signals with soluble Jagged-1 or γ-secretase inhibitors 273. 
However, Notch activation in the absence of co-culture, using immobilized Jagged, was not 
sufficient to trigger cardiac differentiation. 
Cross-species comparisons 
• Notch typically inhibits cardiogenesis in avians, amphibians and flies (fish not studied). 
• In mice Notch affects chamber identity and trabeculation and is required for normal right 
ventricular development, not apparently an inhibitor of cardiac specification. 
• In mouse ESCs, Notch activation at the time of mesoderm induction blocks cardiac 
differentiation, but activation in hemangioblasts promotes it 
Other pathways 
Hedgehog 
Hedgehog (Hh) ligands bind to Patched (Ptc) 12-span transporter-like receptors, which 
in the absence of ligand inhibit the signaling function of Smoothened (Smo) serpentine 
receptors 274 (Figure 1). When bound, Ptc disinhibits Smo, promotes in mammals the 
accumulation of Smo in an organelle called the primary cilium, and enables gene regulation by 
Gli transcription factors, including both activators and repressors 274.  
In Drosophila, hh is required for tinman expression and dorsal vessel formation, via its 
requirement as an inducer of wg 167. Conversely, over-expressing hh (like wg) increased the 
number of eve-positive heart precursor cells as much as four-fold 167. More specifically, hh 
contributes to the segmental identity of cardioblasts in the dorsal vessel, which express tinman 
or the COUP-TFII ortholog seven-up in mutually exclusive fashion, the latter contributing to the 
valve-like openings (ostia) of the heart tube 275. Seven-up induction depends on hh from the 
dorsal ectoderm. Hence, hh loss-of-function mutants lack seven-up but express tinman 
ectopically in the normally seven-up-positive cells.  
A cell-autonomous role for hh signaling in cardiac development was shown in zebrafish 
276 (Figure 3). Smo loss-of-function mutants and inhibition of Smo with cyclopamine demonstrate 
the hh requirement in early cardiac specification during and just after gastrulation. Conversely, 
over-expressing sonic hedgehog (shh) or the combined loss of ptc1 and ptc2 generated a 
surplus of cardiomyocytes. Expansion of the heart field was seen early during cardiogenesis, 
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leading to an increase in pan-cardiac differentiation and both ventricular and atrial cell numbers. 
Much later in development, though, the atrial and ventricular numbers diverged, the ventricle no 
longer exhibiting an increase whereas the atrium did. Thus, there may exist additional effects of 
enhanced hh signaling on longer-term ventricle maintenance.  
In mice, major cardiac effects of the hedgehog pathway include left-right asymmetry, 
angiogenesis, septation, and outflow tract morphogenesis 277-279. However, closer analysis of the 
cardiac cresent in mice lacking Ptc or Smo revealed broader or delayed expression of Nkx2-5, 
respectively, consistent with the operation of Ptc as a repressor of Smo activity 277. Thus, 
hedgehog signals were obligatory for normal induction of Nkx2-5 or its equivalent in both fish 
and mice. Indeed, cardiac progenitor cells in mouse embryos are responsive to Hh, as revealed 
by a Hh-dependent fate-mapping strategy using Cre expressed from the Gli1 locus 276. This 
method irreversibly tags the progeny of cells in which Cre was formerly expressed 280. 
Large effects of the Hh pathway on cardiac myogenesis were seen in P19 cells and their 
Cl6 derivatives 281 282. Over-expressing Shh suffices to induce Nkx2-5, Gata4, Mef2c, and 
sarcomeric MyHC in aggregated P19 cells in the absence of dimethylsulfoxide, ordinarily 
required as a cardiogenic signal for that line 281. Pointing to a requirement for additional signals 
or competence factors induced by aggregation, Shh was ineffective in P19 cell monolayers. In 
P19Cl6 cells, cyclopamine blocked the induction of Gata4, Nkx2-5 and Actn2, confirming a 
requirement for endogenous Hh signals 282. 
Retinoic acid 
RA, the biologically active derivative of vitamin A, is produced by retinaldehyde 
dehydrogenase 2 (Raldh2) as the rate-limiting step, and regulates gene expression directly via 
nuclear RA receptors and their heterodimerization partners, the retinoid X receptors 283.  
Raldh2 is expressed throughout the early zebrafish embryo 284, 285. The zebrafish mutant, 
neckless (nls), disrupts the raldh2 gene, causing an increased fate transformation of anterior 
lateral plate mesoderm to nkx2.5+ cardiac progenitors and a subsequent increase in 
cardiomyocyte numbers 286 (Figure 3). This effect is mimicked by a pan-retinoic acid receptor 
antagonist, BMS189453, allowing precise temporal control of RA inhibition and placing the 
requirement for RA at gastrulation and earlier. RA signals during gastrulation restrict the number 
of both atrial and ventricular cells, while inhibition of RA after specification of the cardiac 
progenitors increases just the atrial cardiomyocytes 287. When RA signaling is reduced, the heart 
field expands into more posterior portions of lateral plate mesoderm, the forelimb bud territory. 
Hoxb5b expression is up-regulated there by loss of RA, and morpholino-induced reduction of 
hoxb5 gives a phenotype similar to the loss of RA itself. Thus, hoxb5 acts as an RA effector to 
inhibit atrial fate, in particular, within the heart field 287. Conversely, ectopic RA or ectopic hoxb5 
diminishes both atrial and ventricular cardiomyocytes at high levels, with a differential response 
at lower ones, augmenting just the atrium 287, 288. 
RA is essential for heart tube formation in Xenopus 289. Blocking RA signals during 
gastrulation causes an increase in cardiac progenitors. However, with continuous treatment, this 
increase in the cardiac pool is not sustained and a net decrease in heart size was observed at 
the time of cardiac differentiation. Chamber specificity was not assayed in this study, and it is 
therefore unknown whether Xenopus is like zebrafish—with treatment after specification 
impeding atrial cell number preferentially. Exposure of Xenopus embryos to RA causes a down 
regulation of cardiac specification genes and cardiac differentiation 289, 290. This is likely 
comparable to high RA treatments in zebrafish, which have a similar effect 291. Thus, in both 
Xenopus and zebrafish RA is a critical factor that, during gastrulation, restricts the cardiac 
progenitor cell pool. Later in development, aspects of differentiation are impeded in both upon 
RA depletion. In contrast, expressing high levels of RA in both species attenuates both 
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specification and differentiation during cardiogenesis, indicating that dose is pivotal. 
In mice, RA and its receptors are essential for cardiac morphogenesis, the atria being 
especially sensitive to loss of Raldh2 292, 293. Associated ventricular hypoplasia has been 
ascribed to the role of RA within the epicardium, inducing Fgf2, Fgf9 and other mitogens for 
myocardial proliferation 229, 294. Using short-term maternal RA supplements to defer the lethality 
of Raldh2 mutants until late gestation, recent studies undertook a more detailed analysis than 
heretofore of Raldh2 effects in the developing heart 295. Interestingly, Raldh2-/- mutant hearts at 
12.5 dpc showed a two-fold increase in cardiac “side population” cells, denoted by a dye-efflux 
phenotype associated with long-term self-renewal. These early cardiac side population cells in 
turn showed a marked increase in progenitor cell markers (Sca-1/Ly6a, Kit, Abcg2) and Nkx2-5 
295.  
RA has been shown to accelerate ESC differentiation into cardiomyocytes 296, 
enhancement also seen using an RXR agonist 297, and RA has been incorporated into protocols 
for large-scale cardiomyocyte production in stirred suspension cultures 298. 
Extracellular signals for cardiac regeneration 
Zebrafish, like newts and axolotls, can regenerate heart tissue along with fins or limbs 
robustly after damage 299. Clearly, a better understanding of how this process occurs might help 
to explain why it occurs only to a very minor extent in mammalian hearts including human ones 
300, 301 and potentially, in the future, could inform attempts to enhance this capacity in the clinic. 
Typically, to evaluate the regenerative capacity of the zebrafish adult heart, 
approximately 20% of the ventricular apex of 1-2 year old fish is surgically removed. Intense but 
transient bleeding follows, but within a minute efficient formation of a blood clot surrounding the 
wound occurs 299, 302. Studies of heart regeneration in zebrafish to date have been somewhat 
contradictory but a consensus is now emerging. The two main areas of confusion have been the 
identity of the actual cells utilised in heart repair and whether or not these re-capitulate the 
normal developmental process. Thus, one group concluded that mature cardiomyocytes were 
not the source of regeneration 54, but their recent work and others’ shows cardiomyocytes to be 
the predominant source, with contributions from other potential populations, such as resident 
progenitor or stem cells, being minimal or non-existent 303, 304. In these latter studies, clear 
evidence for de-differentiation was found in cardiomyocytes at the margin of the regenerating 
region 303, whereas others found no evidence that a cardiac developmental programme is re-
activated or acknowledged minimal de-differentiation 54, 302, 304. 
What tools best attest to the cell origins? Earlier work by Ken Poss and colleagues used 
transgenic zebrafish lines carrying cmlc2: nucDsRed2 and cmcl2:EGFP reporter genes, 
expressing fluorescent proteins under the control of the cardiac myosin light chain-2 gene, to 
track the new myocardium 54: GFP folds and fluoresces more rapidly than DsRed2 but is less 
stable, and new cardiomyocytes appeared to arise from GFP+RFP- cells, prompting the 
inference they were derived from undifferentiated progenitors not pre-existing cardiomyocytes. 
However, the lesser sensitivity of nuclear-localized DsRed2 is misleading in this context 303. 
Recent work, using gata4:EGFP, showed that gata4 is reinduced throughout the myocardium 
after injury (in other words, in mature cardiomyocytes), then used gata4 or cmlc2 to drive 
tamoxifen-activated Cre recombinase for fate-mapping with a Cre-dependent fluorescent 
reporter 303. Together these studies showed conclusively that pre-existing cardiomyocytes 
nearest to the injury are induced to proliferate. Thus, mature cardiomyocytes acquire an 
immature (gata4+, proliferation-competent) phenotype as a response to injury.  
Juan Carlos Izpisua-Belmonte and his team arrived at a similar conclusion with respect 
to cell source, using a similar drug-inducible fate-mapping strategy 304. Because tamoxifen was 
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withdrawn a week or more before amputation, the regenerated cardiomyocytes were proven to 
arise from differentiated cardiomyocytes. Despite concordance as to cell origins there remains 
disagreement about the extent of dedifferentiation within the cardiac muscle lineage. In 
regenerating zebrafish hearts, Izpisua-Belmonte saw induction of msxB and msxC—genes that 
are not expressed in developing zebrafish hearts but are known repressors of differentiation in 
the regenerating fin—as well as notch1b and its ligand deltaC, but no increase in early cardiac 
markers like nkx2.5, hand2, and tbx20 by in situ hybridization or microarray profiling 302, 304, 305. 
Thus, while the extent of de-differentiation is still under debate, both groups agree that the 
source of regenerating cardiomyocytes is pre-existing cardiomyocytes.  
After cardiac injury, cells from the epicardial layer invade the regenerating myocardium, 
making them candidate contributors to the regeneration of cardiomyocytes 54, although lineage 
tracing has not yet been carried out. The regeneration process is dependent on FGF signaling, 
as shown using a dominant-negative receptor, and a clear consequence of blocking this 
pathway is the failure to activate epicardial genes like tbx18 and mobilize the epicardium 54. 
Based on the induction of fgf17b in myocardium and of fgfr2 and fgfr4 in epicardium 54, the 
model emerging is that FGFs are induced in the myocardium in response to damage, which in 
turn induces gene expression changes and mobilization of the epicardium. A likely scenario 
based on mouse studies so far is that these cells contribute new vasculature, which supports 
the generation of new myocardium 306. 
In summary, the best data presently available argue that highly regenerative species, at 
least the zebrafish, do not have more or better stem cells than mammals do, but rather partial 
de-differentiation or looser cell cycle constraints, enabling the fully mature cardiomyocyte to 
relapse to a state that is competent to respond to mitogenic signals. This reinterpretation of the 
zebrafish regenerative phenotype is consistent with prior studies showing up-regulation of other 
mitogens like platelet-derived growth factors in the injured zebrafish heart, which can drive 
cycling even by adult zebrafish cardiomyocytes, and with the demonstrated requirement for 
signals from the platelet-derived growth factor receptor 307.  
New horizons  
Decades of work on the biological signals directing cardiac muscle creation have 
progressed from anatomically precise but biochemically undefined cues, to the current state of 
genetic and genomic knowledge regarding multiple major cardiogenic pathways (Figure 2). 
Nevertheless, the application of this knowledge to inform cardiac myogenesis in any therapeutic 
context is not straightforward, and a few gaps in current understanding bear particular mention.  
First, despite insights regarding the cardiac muscle lineage per se, ultimately it will be 
important to understand equally well the specification of cardiac muscle sub-types. At a 
fundamental level, this distinction is most blatant with the recognition that cardiomyocytes arise 
from multiple sources in the embryo—the first heart field, second heart field, and epicardium—
subserved by different transcriptional machinery. At a translation level, this distinction poses a 
simple but now pressing question: do stem cells from different regions of the heart make 
working cardiomyocytes that are electrically and mechanically equivalent? If not, and if the 
chamber of origin materially affects the functional outcome of grafting cells or prosthetic tissue 
into a high-pressure ventricle, then important consequences could arise for the source and 
design of human cell products. Alternatively, if such transitions were much better understood, ex 
vivo strategies might be pursued to confer the desired fate (likely a left ventricular one, for the 
predominant forms of heart disease).  
Second, although new layers of epigenetic control have come to be understood in 
cardiac biology 308, 309, much remains to be learned mechanistically about where and how the 
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instructive cardiogenic pathways intersect other essential regulators like microRNA networks 
and chromatin modification.  
Third, the positive and negative effects of cardiogenic signals are frequently 
contradictory, even within a single species or cell line depending on the developmental stage, 
and sometimes invert within a few hours. “Repressors” like canonical Wnts can be essential, 
and “essential inducers” like BMPs can repress. While not quite grounds for therapeutic nihilism, 
this problem is daunting and defies simple linear models and conventional means of hypothesis-
testing. Complexities of integration, cross-talk, feed-forward mechanisms and feedback loops 
entangle even the partial set of signaling relationships discussed here. Indeed, apart from a 
handful of serial relationships, a hierarchical model or even cartoon of interactions among the 
major cardiogenic pathways would be premature at this time, in the absence of more finely 
grained microarray studies using various pathway inhibitors, together with reporter genes to 
delineate the net effect of cross-talk, ChIP-chip to define the pathways’ direct targets, and 
methods that integrate these multi-level findings into a formal scheme. Two ways out of the 
labyrinth are suggested by systems biology 310, 311: quantitative computational modeling of 
cardiogenic networks and their interactions, plus “higher bandwidth” empirical testing of 
combinatorial growth factors, inhibitors and mediators. Encouraging success has already been 
achieved with a chemical genetics approach to elicit the cardiac phenotype 312, 313 (M. Mercola, 
unpublished data, 2010).  
Lastly, the “holy grail” in heart repair might not be progenitor and stem cells themselves, 
or even engineered cardiac tissue, but rather the pharmacological augmentation of human self-
repair in situ. Reported cardioprotective factors such as sFRP2 314, 315, sonic hedgehog 316, 
thymosin β4 317 and neuregulin 318 might fruitfully be examined for effects on the latent cardiac 
stem cell population, and high-throughput methods might be deployed using adult heart-derived 
cells, much as implemented for cardiac myogenesis in differentiating ESCs. 
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Figure legends  
Figure 1. Summary of major signaling cascades controlling cardiopoiesis. From left to 
right are shown schematically the BMP, Activin/Nodal, canonical Wnt, noncanonical Wnt, FGF 
and Notch pathways. For details of each, please see the text.  ligand; , ligand antagonist; 
, receptor ligand-binding and signaling domains (light and dark, respectively); , protein 
kinase; , G-protein; , scaffold protein; , protease; , transcription factor. 
Figure 2. Signals for cardiac muscle creation during embryogenesis and stem cell 
differentiation. Solid and dashed lines indicate positive and negative signals, respectively, at 
the indicated developmental stages. Circular arrows denote self-renewal. Timing relative to 
Mesp1 is inferred in some instances, e.g., by the presence of mesoderm derivatives known to 
require Mesp genes. 
Figure 3. Temporal and spatial signaling requirements for cardiac muscle creation in 
zebrafish. (Upper panel, left) Positive (red) and negative (blue) inputs from the cardiogenic 
pathways shown and their relative requirement before, during and after gastrulation. (Upper 
panel, right) Principal contributions of the pathways to the atrium and ventricle, respectively. 
Later contributions to the chambers during somitogenesis are represented by dashed arrows. 
(Lower panel) Bars depict the timing of experimental interventions directed at each pathway 
(blue, inhibition; red, activation). Effects on cardiomyocyte numbers are highlighted at the right 
in the grey boxes (up arrow, increase; down arrow, decrease; tilde, unchanged). Specification 
(spec) was determined wherever possible from observations during specification or was inferred 
from the expression of specification genes at later stages. Differentiation (diff) is shown for the 
atrium (A) and ventricle (V), if reported for both individually.  
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